D-glutamate auxotrophy. Nat Commun
8:15480
90. Serruto D, Serino L, Masignani V, Pizza M
(2009) Genome-based approaches to develop
vaccines against bacterial pathogens. Vaccine
27(25–26):3245–3250
91. Essig A, Longbottom D (2015) Chlamydia
abortus: new aspects of infectious abortion
in sheep and potential risk for pregnant
women. Curr Clin Microbiol Rep 2(1):22–34
92. Phillips S, Quigley BL, Timms P (2019) Seventy years of Chlamydia vaccine research–limitations of the past and directions for the
future. Front Microbiol 10:70. https://doi.
org/10.3389/fmicb.2019.00070
93. Sharma A, Rajan G, Kharb R, Biswas S (2016)
Genome wide analysis of Chlamydia pneumoniae for candidate vaccine development. Curr
Comput Aided Drug Des 12(3):206–215
94. Bi Q, Ferreras E, Pezzoli L et al (2017) Protection against cholera from killed whole-cell
oral cholera vaccines: a systematic review and
meta-analysis. Lancet Infect Dis 17
(10):1080–1088
95. Chowdhury SR, Sarkar A, Kumar RP,
Kumar V, Saxena D, Barman BD (2018) Periodontal vaccine–a review. J Adv Med Dent
Scie Res 6(3):4–9
96. de Castro JT, Miyaji EN, Soares-Schanoski A,
Debrie AS, Bezerra MF, Akamatsu MA, de
Oliveira MS (2018) Whole cell pertussis vaccine expressing the Pneumococcal Surface
protein A as an approach for a double vaccine.
Int J Infect Dis 73:356
97. Soema PC, Kompier R, Amorij JP, Kersten
GF (2015) Current and next generation influenza vaccines: formulation and production
strategies.
Eur
J
Pharm
Biopharm
94:251–263
98. Kraan H, ten Have R, van der Maas L,
Kersten G, Amorij JP (2016) Incompatibility
of lyophilized inactivated polio vaccine with
liquid pentavalent whole-cell-pertussis-containing vaccine. Vaccine 34(38):4572–4578
99. Zhang W, Cheng N, Wang Y, Zheng X,
Zhao Y, Wang H, Yang S (2019) Adjuvant
activity of PCP-II, a polysaccharide from
Poria cocos, on a whole killed rabies vaccine.
Virus Res 270:197638. https://doi.org/10.
1016/j.virusres.2019.06.001
100. Domenech de Celle `s M, Magpantay FM,
King AA, Rohani P (2016) The pertussis
enigma: reconciling epidemiology, immunology and evolution. Proc R Soc Lond B Biol
Sci 283(1822):20152309
101. Mattia G, Puglisi R, Ascione B, Malorni W,
Care ` A, Matarrese P (2018) Cell death-based
treatments of melanoma: conventional treatments and new therapeutic strategies. Cell
Death Dis 9(2):112. https://doi.org/10.
1038/s41419-017-0059-7
102. Yarchoan M, Johnson BA III, Lutz ER,
Laheru DA, Jaffee EM (2017) Targeting
neoantigens to augment antitumour immunity. Nat Rev Cancer 17(4):209
103. Keenan BP, Jaffee EM (2012) Whole cell vaccines—past progress and future strategies.
Semin Oncol 39(3):276–286. https://doi.
org/10.1053/j.seminoncol.2012.02.007
104. Barouch DH, Letvin NL, Seder RA (2004)
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune
responses. Immunol Rev 202(1):266–274
105. Kongsted P, Borch TH, Ellebaek E, Iversen
TZ, Andersen R, Met O ¨ , Svane IM (2017)
Dendritic cell vaccination in combination
with docetaxel for patients with metastatic
castration-resistant prostate cancer: a randomized phase II study. Cytotherapy 19
(4):500–513
106. World Health Organization fact sheet Cholera. https://www.who.int/news-room/factsheets/detail/cholera. Accessed 28 July 2019
107. Gupta SS, Bharati K, Sur D, Khera A,
Ganguly NK, Nair GB (2016) Why is the
oral cholera vaccine not considered an option
for prevention of cholera in India? Analysis of
possible reasons. Indian J Med Res 143
(5):545–551.
https://doi.org/10.4103/
0971-5916.187102
108. Ciglenecki I, Bichet M, Tena J, Mondesir E
(2013) Cholera in pregnancy: outcomes from
a specialized cholera treatment unit for pregnant women in Leogane. Haiti PLoS Negl
Trop Dis 7:e2368
109. Grout L, Martinez-Pino I, Ciglenecki I,
Keita S, Traore B, Delamou D, Serafini M
(2015) Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in Guinea: a retrospective cohort study.
PLoS Negl Trop Dis 9(12):e0004274
110. Khan AI, Ali M, Lynch J, Kabir A, Excler JL,
Khan MA, Islam MT, Akter A, Chowdhury F,
Saha A, Khan IA, Desai SN, Kim DR, Saha
NC, Singh AP, Clemens JD, Qadri F (2019)
Safety of a bivalent, killed, whole-cell oral
cholera vaccine in pregnant women in
Bangladesh: evidence from a randomized
placebo-controlled trial. BMC Infect Dis 19
(1):422. https://doi.org/10.1186/s12879019-4006-3
111. Khan AI, Chowdhury F, Leung DT, Larocque RC, Harris JB, Ryan ET, Calderwood SB,
Qadri F (2015) Cholera in pregnancy: clinical
Whole-Cell Vaccine Preparation: Options and Perspectives
265
8:15480
90. Serruto D, Serino L, Masignani V, Pizza M
(2009) Genome-based approaches to develop
vaccines against bacterial pathogens. Vaccine
27(25–26):3245–3250
91. Essig A, Longbottom D (2015) Chlamydia
abortus: new aspects of infectious abortion
in sheep and potential risk for pregnant
women. Curr Clin Microbiol Rep 2(1):22–34
92. Phillips S, Quigley BL, Timms P (2019) Seventy years of Chlamydia vaccine research–limitations of the past and directions for the
future. Front Microbiol 10:70. https://doi.
org/10.3389/fmicb.2019.00070
93. Sharma A, Rajan G, Kharb R, Biswas S (2016)
Genome wide analysis of Chlamydia pneumoniae for candidate vaccine development. Curr
Comput Aided Drug Des 12(3):206–215
94. Bi Q, Ferreras E, Pezzoli L et al (2017) Protection against cholera from killed whole-cell
oral cholera vaccines: a systematic review and
meta-analysis. Lancet Infect Dis 17
(10):1080–1088
95. Chowdhury SR, Sarkar A, Kumar RP,
Kumar V, Saxena D, Barman BD (2018) Periodontal vaccine–a review. J Adv Med Dent
Scie Res 6(3):4–9
96. de Castro JT, Miyaji EN, Soares-Schanoski A,
Debrie AS, Bezerra MF, Akamatsu MA, de
Oliveira MS (2018) Whole cell pertussis vaccine expressing the Pneumococcal Surface
protein A as an approach for a double vaccine.
Int J Infect Dis 73:356
97. Soema PC, Kompier R, Amorij JP, Kersten
GF (2015) Current and next generation influenza vaccines: formulation and production
strategies.
Eur
J
Pharm
Biopharm
94:251–263
98. Kraan H, ten Have R, van der Maas L,
Kersten G, Amorij JP (2016) Incompatibility
of lyophilized inactivated polio vaccine with
liquid pentavalent whole-cell-pertussis-containing vaccine. Vaccine 34(38):4572–4578
99. Zhang W, Cheng N, Wang Y, Zheng X,
Zhao Y, Wang H, Yang S (2019) Adjuvant
activity of PCP-II, a polysaccharide from
Poria cocos, on a whole killed rabies vaccine.
Virus Res 270:197638. https://doi.org/10.
1016/j.virusres.2019.06.001
100. Domenech de Celle `s M, Magpantay FM,
King AA, Rohani P (2016) The pertussis
enigma: reconciling epidemiology, immunology and evolution. Proc R Soc Lond B Biol
Sci 283(1822):20152309
101. Mattia G, Puglisi R, Ascione B, Malorni W,
Care ` A, Matarrese P (2018) Cell death-based
treatments of melanoma: conventional treatments and new therapeutic strategies. Cell
Death Dis 9(2):112. https://doi.org/10.
1038/s41419-017-0059-7
102. Yarchoan M, Johnson BA III, Lutz ER,
Laheru DA, Jaffee EM (2017) Targeting
neoantigens to augment antitumour immunity. Nat Rev Cancer 17(4):209
103. Keenan BP, Jaffee EM (2012) Whole cell vaccines—past progress and future strategies.
Semin Oncol 39(3):276–286. https://doi.
org/10.1053/j.seminoncol.2012.02.007
104. Barouch DH, Letvin NL, Seder RA (2004)
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune
responses. Immunol Rev 202(1):266–274
105. Kongsted P, Borch TH, Ellebaek E, Iversen
TZ, Andersen R, Met O ¨ , Svane IM (2017)
Dendritic cell vaccination in combination
with docetaxel for patients with metastatic
castration-resistant prostate cancer: a randomized phase II study. Cytotherapy 19
(4):500–513
106. World Health Organization fact sheet Cholera. https://www.who.int/news-room/factsheets/detail/cholera. Accessed 28 July 2019
107. Gupta SS, Bharati K, Sur D, Khera A,
Ganguly NK, Nair GB (2016) Why is the
oral cholera vaccine not considered an option
for prevention of cholera in India? Analysis of
possible reasons. Indian J Med Res 143
(5):545–551.
https://doi.org/10.4103/
0971-5916.187102
108. Ciglenecki I, Bichet M, Tena J, Mondesir E
(2013) Cholera in pregnancy: outcomes from
a specialized cholera treatment unit for pregnant women in Leogane. Haiti PLoS Negl
Trop Dis 7:e2368
109. Grout L, Martinez-Pino I, Ciglenecki I,
Keita S, Traore B, Delamou D, Serafini M
(2015) Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in Guinea: a retrospective cohort study.
PLoS Negl Trop Dis 9(12):e0004274
110. Khan AI, Ali M, Lynch J, Kabir A, Excler JL,
Khan MA, Islam MT, Akter A, Chowdhury F,
Saha A, Khan IA, Desai SN, Kim DR, Saha
NC, Singh AP, Clemens JD, Qadri F (2019)
Safety of a bivalent, killed, whole-cell oral
cholera vaccine in pregnant women in
Bangladesh: evidence from a randomized
placebo-controlled trial. BMC Infect Dis 19
(1):422. https://doi.org/10.1186/s12879019-4006-3
111. Khan AI, Chowdhury F, Leung DT, Larocque RC, Harris JB, Ryan ET, Calderwood SB,
Qadri F (2015) Cholera in pregnancy: clinical
Whole-Cell Vaccine Preparation: Options and Perspectives
265